The use of novel agents in the treatment of relapsed and refractory multiple myeloma

Although outcomes for patients with multiple myeloma (MM) have improved over the past decade, the disease remains incurable and even patients who respond well to induction therapy ultimately relapse and require additional treatment. Conventional chemotherapy and high-dose therapy with stem cell tran...

Full description

Saved in:
Bibliographic Details
Main Authors: Laubach, JP, Mahindra, A, Mitsiades, CS, Schlossman, RL, Munshi, NC, Ghobrial, IM, Carreau, N, Hideshima, T, Anderson, KC, Richardson, PG
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3133628/
https://ncbi.nlm.nih.gov/pubmed/19741729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2009.179
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items